Results 271 to 280 of about 101,810 (380)

Identifying Subcellular Structure Components in Escherichia Coli by Crosslinking and SEC‐MS

PROTEOMICS, EarlyView.
ABSTRACT Cells are comprised of a broad spectrum of structures that compartmentalize biochemical and signaling mechanisms. These structures can be comprised of many biomolecules, but especially lipids, proteins, and nucleic acids. Techniques are limited to quantify or discover new subcellular structures.
Rachel A. Victor, Austin Lipinski, Paul R. Langlais, Jacob C. Schwartz   +3 more
wiley   +1 more source

Transformative roles of digital twins from drug discovery to continuous manufacturing: pharmaceutical and biopharmaceutical perspectives. [PDF]

Int J Pharm X
Maharjan R, Kim NA, Kim KH, Jeong SH.
europepmc   +1 more source

Innovation Policy and the Economy, Volume 10 [PDF]

Iain M. Cockburn, Matthew J. Slaughter
core  

Modeling impact of inflation reduction act price negotiations on new drug pipeline considering differential contributions of large and small biopharmaceutical companies [PDF]

Gregory Vaughan, Roger Du, Fred D. Ledley   +2 more
openalex   +1 more source

Economic Analysis of Batch and Continuous Biopharmaceutical Antibody Production: a Review

Journal of Pharmaceutical Innovation, 2019
O. Yang, Maen Qadan, M. Ierapetritou
semanticscholar   +1 more source

Advancing pharmacometrics in Africa—Transition from capacity development toward job creation

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 407-419, March 2025.
Abstract Trained pharmacometricians remain scarce in Africa due to limited training opportunities, lack of a pharmaceutical product development ecosystem, and emigration to high‐income countries. The Applied Pharmacometrics Training (APT) fellowship program was established to address these gaps and specifically foster job creation for talent retention.
Goonaseelan (Colin) Pillai, Samer Mouksassi, Innocent G. Asiimwe, Craig R. Rayner, Steven Kern, Phumla Sinxadi, Paolo Denti, Eric Decloedt, Catriona Waitt, Bernhards R. Ogutu, Rik de Greef   +10 more
wiley   +1 more source

Licensing exchange: Insights from the biopharmaceutical industry. [PDF]

Dutta, S., Wuyts, S.H.K.
core   +1 more source

Modeling of Disease Progression of Type 2 Diabetes Using Real‐World Data: Quantifying Competing Risks of Morbidity and Mortality

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 606-615, March 2025.
ABSTRACT Type 2 diabetes (T2D) is a progressive metabolic disorder that could be an underlying cause of long‐term complications that increase mortality. The assessment of the probability of such events could be essential for mortality risk management. This work aimed to establish a framework for risk predictions of macrovascular complications (MVC) and
Hanna Kunina, Stefan Franzén, Maria C. Kjellsson   +2 more
wiley   +1 more source

Optimizing clarification processes in biopharmaceutical manufacturing through quality by design: Strategies, implications, and future prospects. [PDF]

Biotechnol Prog
Yeop KW, Nam HJ, Shim CJ, Yang SM, Kim HW, Park CI, Banerjee S, Mok Y.   +7 more
europepmc   +1 more source

Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges.

Advanced Drug Delivery Reviews, 2019
P. Joyce, Tahnee J Dening, Tahlia R. Meola, H. B. Schultz, R. Holm, Nicky Thomas, C. Prestidge   +6 more
semanticscholar   +1 more source